SOTATERCEPT-CSRK for Pulmonary arterial hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 595 adverse event reports in the FDA FAERS database where SOTATERCEPT-CSRK was used for Pulmonary arterial hypertension.
Most Reported Side Effects for SOTATERCEPT-CSRK
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Headache | 187 | 11.8% | 2 | 54 |
| Epistaxis | 151 | 9.5% | 0 | 38 |
| Diarrhoea | 132 | 8.3% | 2 | 44 |
| Haemoglobin increased | 100 | 6.3% | 3 | 18 |
| Dyspnoea | 93 | 5.9% | 5 | 65 |
| Fatigue | 93 | 5.9% | 2 | 38 |
| No adverse event | 93 | 5.9% | 0 | 0 |
| Dizziness | 90 | 5.7% | 2 | 37 |
| Nausea | 88 | 5.6% | 1 | 32 |
| Dyspnoea exertional | 61 | 3.9% | 1 | 23 |
| Pericardial effusion | 60 | 3.8% | 0 | 26 |
| Platelet count decreased | 49 | 3.1% | 4 | 14 |
| Rash | 49 | 3.1% | 1 | 9 |
| Pneumonia | 47 | 3.0% | 2 | 45 |
| Product dose omission issue | 47 | 3.0% | 0 | 6 |
Other Indications for SOTATERCEPT-CSRK
Other Drugs Used for Pulmonary arterial hypertension
TREPROSTINIL (72,609)
MACITENTAN (29,246)
AMBRISENTAN (27,852)
BOSENTAN (12,387)
SELEXIPAG (11,861)
RIOCIGUAT (9,158)
EPOPROSTENOL (8,508)
TADALAFIL (7,679)
SILDENAFIL (5,239)
ILOPROST (2,828)